FDA approves ASCENIV for the treatment of primary humoral immunodeficiency disease

ADMA Biologics, a vertically integrated commercial biopharmaceutical and specialty immunoglobulin company that manu...

April 2, 2019 | Tuesday | News
Jonas Bergh receives first ESMO Breast Cancer Award

The European Society for Medical Oncology (ESMO) announced that Prof. Jonas Bergh from the Karolinska Institutet in Stoc...

April 2, 2019 | Tuesday | News
Thermo Fisher showcases clinical analytical solutions at MSACL US 2019

Thermo Fisher Scientific announces the expansion of its portfolio of analytical instruments for clinical diagnostic labo...

April 2, 2019 | Tuesday | News
FDA advances policy changes to modernize mammography

The U.S. Food and Drug Administration (FDA) has announced important new steps to modernize breast cancer screening and h...

April 2, 2019 | Tuesday | News
Celgene receives positive CHMP opinion for lenalidomide and pomalidomide for multiple myeloma patients

Celgene Corporation has announced that the European Medicines Agency's (EMA) Committee for Medicinal Products for Human ...

April 1, 2019 | Monday | News
Boehringer Ingelheim acquires ICD Therapeutics

Boehringer Ingelheim has announced that it has acquired ICD Therapeutics. The acquisition includes rights to ICD&rs...

April 1, 2019 | Monday | News
Cambridge Innovation Capital raises GBP150 million

Cambridge Innovation Capital plc (CIC), the venture capital investor focused on intellectual property rich technology an...

April 1, 2019 | Monday | News
Diseases cost the African Region $2.4 trillion a year: WHO

The World Health Organization (WHO) estimates that nearly 630 million years of healthy life were lost in 2015 due to the...

April 1, 2019 | Monday | News
Scientists identify FLIP Inhibitors for cancer treatment

Queen’s University Belfast and Domainex are pleased to announce that their joint project team has successfull...

March 29, 2019 | Friday | News
EmeryStation West secures lease with Novartis

Wareham Development announced that it has executed a lease for 78,000 square feet over several floors of the newly-const...

March 29, 2019 | Friday | News
Gilead launches HepConnect initiative to combat Hepatitis C infections

Gilead Sciences, Inc. has announced HepConnect, a five-year, multi-million dollar initiative aimed at addressing the sha...

March 29, 2019 | Friday | News
Novartis’ Mayzent gets FDA nod to treat multiple sclerosis

Novartis has received the US Food and Drug Administration (FDA) approval of Mayzent® (siponimod) for the treatm...

March 27, 2019 | Wednesday | News
Lilly, ImmuNext to develop new medicines for autoimmune diseases

Eli Lilly and Company and ImmuNext, Inc. have announced a global licensing and research collaboration focused on the stu...

March 27, 2019 | Wednesday | News
Scientist Kiana Aran makes digital detection of DNA without amplification possible

Researchers have found multiple applications for the CRISPR (Clustered Regularly Interspersed Short Palindromic Repeats)...

March 26, 2019 | Tuesday | News
Pilloxa initiates a strategic partnership with Bayer AB

Swedish digital health start-up Pilloxa has entered a strategic collaboration with Bayer AB. Pilloxa helps patients ta...

March 26, 2019 | Tuesday | News
Impulse Dynamics receives FDA approval for breakthrough Optimizer®

Impulse Dynamics, developer of the implantable Optimizer® Smart System for delivering CCM™ therapy, annou...

March 25, 2019 | Monday | News
Muno-Vax Biotechnologies launches Dentavax to combat gingivitis

Dentavax, developed by Muno-Vax Biotechnologies, gives your oral mucosa's immune system a boost to minimize gingivitis, ...

March 25, 2019 | Monday | News
Ascendis Pharma announces top-line results for Ph3 heiGHt Trial

Ascendis Pharma A/S, a biopharmaceutical company that utilizes its innovative TransCon technology to address unmet medic...

March 25, 2019 | Monday | News